Susquehanna International Group’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,965
Closed -$32.6K 13139
2023
Q4
$32.6K Buy
+2,965
New +$33.1K ﹤0.01% 11856
2023
Q3
Sell
-1,812
Closed -$99.5K 12799
2023
Q2
$99.5K Buy
1,812
+655
+57% +$41.7K ﹤0.01% 10952
2023
Q1
$78.8K Buy
+1,157
New +$90K ﹤0.01% 11441
2022
Q4
Sell
-547
Closed -$55K 13454
2022
Q3
$55K Sell
547
-3,165
-85% -$369K ﹤0.01% 12136
2022
Q2
$327K Sell
3,712
-1,668
-31% -$204K ﹤0.01% 9351
2022
Q1
$817K Buy
+5,380
New +$1M ﹤0.01% 7657
2021
Q2
Sell
-1,636
Closed -$488K 13137
2021
Q1
$488K Buy
+1,636
New +$501K ﹤0.01% 9523

Other funds holding RBOT

Susquehanna International Group's RBOT Position: Q1 2024 in Review

Susquehanna International Group sold out of Vicarious Surgical (RBOT) in Q1 2024, closing a stake of 2,965 shares — an estimated $32.6K sold.

Susquehanna International Group first reported a position in RBOT in Q1 2021 and held it in 7 quarters. The position peaked at $817K in Q1 2022. 72 funds tracked by Wall St. Rank hold RBOT as of Q1 2024.

  • Susquehanna International Group reported no remaining Vicarious Surgical position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 2,965 Vicarious Surgical shares in Q1 2024, an estimated $32.6K.
  • Susquehanna International Group first reported a position in Vicarious Surgical in Q1 2021 and held it in 7 quarters.
  • Susquehanna International Group's Vicarious Surgical position peaked at $817K in Q1 2022.
  • 72 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.